Avoro Capital Advisors LLC - 30 Jun 2025 SCHEDULE 13G/A Report for ARROWHEAD PHARMACEUTICALS, INC. Common Stock, par value $0.001 per share (ARWR)

Filing Manager: Avoro Capital Advisors LLC
Reporting Manager: Avoro Capital Advisors LLC
Security: ARROWHEAD PHARMACEUTICALS, INC. Common Stock, par value $0.001 per share
Symbol: ARWR
Shares outstanding: 138,764,349 shares
Disclosed Ownership: 11,517,441 shares
Ownership: 8.3%
Form type: SCHEDULE 13G/A
Filing time: 14 Aug 2025, 07:07:30 UTC
Date of event: 30 Jun 2025
Previous filing: 14 Feb 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Avoro Capital Advisors LLC	8.3%	11,517,441	11,517,441	0	/s/ Scott Epstein	Scott Epstein, Chief Financial Officer & Chief Compliance Officer
Behzad Aghazadeh	8.3%	11,517,441	11,517,441	0	/s/ Behzad Aghazadeh	Behzad Aghazadeh, Individually